HIGHLIGHTS
- who: Report and colleagues from the Internal Medicine, Northwell Health, Staten Island, USA have published the research work: Open Access Case Rare Case of Reversible Pulmonary Arterial Hypertension Secondary to Cyclophosphamide Review began 06/20/2022 Review ended 06/21/2022, in the Journal: (JOURNAL) of June/22,/2022
SUMMARY
Pulmonary arterial hypertension (PAH) is characterized as a resting mean pulmonary artery pressure >25mmHg. Group one is known as PAH due to narrowing of the pulmonary arteries, which can be idiopathic, hereditary, or drugrelated. Lastly, group five's etiology is unclear/multifactorial such . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.